{
Zur Rose Group AG

Companies

}
001122334455554433221100
001122334455554433221100

UBS lowers DocMorris price target amid tough competition and consumer hesitance

UBS has downgraded the price target for DocMorris from 25 to 16 francs, maintaining a "Sell" rating. Analyst Sebastian Vogel cites ongoing tough competition and slow shifts in consumer behavior as reasons for revising market share assumptions and lowering estimates for operating margin and earnings per share.
boerse.de
Swiss Franc Zur Rose Group AG DEU Sebastian Vogel
Finance & Economy, Market Report
08:01 07.02.2025

UBS maintains sell rating for Zur Rose Group with target price of 25 francs

UBS has maintained a "Sell" rating for DocMorris, setting a target price of 25 francs. Analyst Sebastian Vogel noted that the online pharmacy fell short of overall expectations, particularly in its prescription business, which was a significant disappointment.
boerse.de
Swiss Franc Zur Rose Group AG CHE Warren Buffett Hubert Dichtl Sebastian Vogel Thomas Müller Show more
Finance & Economy, Market Report
12:39 21.01.2025

Zur Rose Group AG maintains sell rating from UBS amid market challenges

Zur Rose Group AG, a Swiss pharmaceutical distributor, operates through two main divisions: Zur Rose, which focuses on wholesale medicine supply to healthcare providers, and DocMorris, which manages mail-order pharmacy sales. The company serves markets in Switzerland, Germany, and the Netherlands via several subsidiaries, including Zur Rose Suisse AG and DocMorris NV.
Zonebourse
Euro Zur Rose Group AG DEU
Business & Industry, Market Report
12:31 21.01.2025

ubs maintains sell rating on zur rose group ag in pharmaceutical sector

Zur Rose Group AG, a Swiss pharmaceutical distributor, operates through two divisions: Zur Rose, which focuses on wholesale medicine supply to healthcare providers, and DocMorris, which manages mail-order pharmacy sales. The company has a presence in Switzerland, Germany, and the Netherlands, with several subsidiaries including Zur Rose Suisse AG and DocMorris NV. UBS has maintained a sell rating on the company.
Zonebourse
Zur Rose Group AG EURAPON Pharmahandel GmbH DocMorris NV NLD CHE DEU Show more
TradFi, Market Report
14:30 12.11.2024

UBS maintains sell rating for DocMorris with price target of 25 francs

UBS has maintained a "Sell" rating for DocMorris, setting a price target of 25 francs. Analyst Olivier Calvet noted ongoing price competition from Redcare and a decline in app activity for DocMorris, indicating that the company is lagging behind its competitor in the German online pharmacy market.
boerse.de
Swiss Franc Zur Rose Group AG CHE DEU Warren Buffet Olivier Calvet
TradFi, Market Report
13:43 12.11.2024

Zur Rose Group AG faces challenges in pharmaceutical distribution sector

Zur Rose Group AG, a Swiss pharmaceutical distribution company, operates through two divisions: Zur Rose, which focuses on wholesale medicine supply to healthcare providers, and DocMorris, which manages mail-order pharmacy sales. The company serves markets in Switzerland, Germany, and the Netherlands via subsidiaries including Zur Rose Suisse AG and DocMorris NV.
Zonebourse
DocMorris NV EURAPON Pharmahandel GmbH Zur Rose Group AG CHE NLD DEU Show more
TradFi, Market Report
11:39 17.10.2024
Trending
Subcategory
Industry Trends Corporate News Supply Chain Management Global Trade Developments Startups & Entrepreneurship Government Economic Policies Industry Mergers & Acquisitions Retail and Consumer Goods Finance Mergers & Acquisitions Financial Scams and Security Fintech Startups Emerging Startups Workplace Trends CEO Changes Venture Capital Investments Cryptocurrency Trends Funding Rounds & Investments Energy Sector Developments Market Analysis and Predictions Stock Market Updates
Countries:
USA IND CHN ARE VNM MAR JPN EGY SAU CAN MEX HKG KOR SGP THA PAK DZA TWN NLD FRA
Companies:
Apple Inc. Google Inc. NVIDIA Corporation Delhivery Limited Ecom Express Ltd. Alphabet Inc. OpenAI ERC USD Ciscom Corp. ERICSSON - CLASS B Physicswallah Ltd. Learning Resources Inc. MGA Entertainment Inc. State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund Snap Inc. Tiktok USD Semiconductor Manufacturing International Corporation Hua Hong Semiconductor Ltd. Spotify Technology S.A. Dropbox, Inc. Vimeo, Inc.
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro United Arab Emirates Dirham Vietnamese Đồng New Taiwan Dollar Russian Ruble South Korean Won Pakistani Rupee Algerian Dinar Australian Dollar Thai Baht Japanese Yen Saudi Riyal
People:
Donald Trump Ilya Sutskever Peter Thiel Amal El Fallah Seghrouchni Trixie Lohmirmand Scott Bessent Jamieson Greer Joe Jurken Stephen Roachford David French Rick Woldenberg Marc Rosenberg Isaac Larian Hichem Djouhri Laurina Emmanuel Tim Cook Andrew Ferguson Sheryl Sandberg Mark Zuckerberg Pavel Prass

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.